Full-Time

Director/Sr. Director

Clinical Supply Chain Management

Confirmed live in the last 24 hours

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology

Compensation Overview

$200k - $275kAnnually

+ Performance Bonus + Equity

Senior, Expert

San Francisco, CA, USA

This is a hybrid position, which may require some in-office days.

Category
Supply Chain Management
Operations & Logistics
Required Skills
Inventory Management
Data Analysis
Google Cloud Platform

You match the following BridgeBio's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • At least ten (10) years of experience in Clinical Supply Chain Management and/or Manufacturing functions in the pharmaceutical and/or biotechnology industries. Title based on experience
  • Bachelor’s or Master’s Degree in a scientific discipline
  • Detailed understanding of the pharmaceutical business, especially clinical development and manufacturing
  • Proven experience with forecasting, demand/supply planning, inventory management, clinical, packaging, labeling, and distribution, including cold chain, import/export, and reverse logistics
  • Experience with clinical blinding practices
  • Experience in assisting with the set-up of IRT Systems for global clinical studies
  • Demonstrated skills in project management and CMO/CRO vendor management
  • Working knowledge of the drug development process (Phase I-IV)
  • Working knowledge of current GMP/GCP/GDP guidance and regulations
  • Familiar with US and EU import/export regulations
  • Excellent attention to detail, strong data analysis, problem-solving solving and decision-making ability, all while working in a fast-paced and dynamic environment
  • Proven ability to effectively develop, communicate, and gain support for execution plans with a wide range of stakeholders
  • Experience with managing and developing staff
  • Ability to handle multiple projects simultaneously
  • Position may require occasional evening and/or weekend commitment
  • Position may require occasional travel (up to 20%), domestic and international.
Responsibilities
  • Manage all aspects of clinical packaging and labeling activities, including label design, translation, production, distribution, and inventory management
  • Act as a key interface between the CMC and clinical operation teams
  • Provide total demand and translate the total demand into a demand forecast over time based on a clinical protocol or study overview
  • Prepare a supply plan to support the demand forecast, including the determination of supply overage amounts, monitor inventory, and provide regular inventory updates to project teams
  • Monitor drug expiry/retest dating; initiate inventory release and re-supply, serving as the unblinded inventory manager
  • Manage domestic and international distribution and logistics for clinical programs, including importing and exporting clinical supplies and developing distribution instructions with clinical supply vendors
  • Coordinate logistics of material transfer for drug substance, drug product, and components to/from international CMO’s, managing exportation, applicable USDA/FDA licenses and permits, VAT recovery, and customs brokers
  • Investigate and work collaboratively with QA to resolve shipping temperature excursions, investigations, and deviations in a timely manner
  • Support budget activities, including managing proposals, contracts, PO generation, and invoicing approvals for clinical packaging/distribution/storage
  • Generate and maintain SOPs and ensure updates and compliance with industry standards
  • Develop strong internal collaboration with stakeholders, such as Clinical Operations, Regulatory Affairs, Quality, Manufacturing, and Pro

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company uses a decentralized subsidiary model, allowing each subsidiary to concentrate on specific therapies while sharing central resources. This structure enhances efficiency and enables the advancement of multiple drug programs at once. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Their goal is to create significant therapeutic improvements by targeting diseases at their genetic source. With over 15 drug programs aimed at 20 different genetic diseases, BridgeBio aims to bring treatments to market more quickly than traditional biopharma processes. The company promotes a culture of independent thinking and transparency, which supports rapid, data-driven decision-making.

Company Stage

IPO

Total Funding

$704.4M

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

4%

1 year growth

3%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investment by Norges Bank shows strong investor confidence in BridgeBio.
  • Partnership with PANTHERx Rare enhances market penetration for rare disease therapies.
  • KRAS inhibitors development positions BridgeBio in a promising cancer treatment market.

What critics are saying

  • Alnylam's RNAi therapy poses competitive pressure on BridgeBio's Attruby.
  • Decentralized model may challenge cohesive strategic direction across programs.
  • Increased competition in KRAS inhibitors could impact BridgeBio's market share.

What makes BridgeBio unique

  • BridgeBio employs a decentralized subsidiary model for efficient drug development.
  • Focus on genetic diseases allows targeting conditions with well-understood genetic causes.
  • Partnerships with specialty pharmacies enhance patient access to rare disease therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Performance Bonus

Company Equity

Unlimited Paid Time Off